A detailed history of Santori & Peters, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Santori & Peters, Inc. holds 1,398 shares of JNJ stock, worth $204,149. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,398
Previous 1,454 3.85%
Holding current value
$204,149
Previous $227,000 2.64%
% of portfolio
0.1%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$155.22 - $162.74 $8,692 - $9,113
-56 Reduced 3.85%
1,398 $221,000
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $8,099 - $9,072
-52 Reduced 3.45%
1,454 $226,000
Q3 2022

Oct 14, 2022

SELL
$161.33 - $179.52 $10,325 - $11,489
-64 Reduced 4.08%
1,506 $246,000
Q2 2022

Jul 13, 2022

BUY
$168.19 - $186.01 $10,764 - $11,904
64 Added 4.25%
1,570 $278,000
Q1 2022

Apr 28, 2022

BUY
$158.14 - $179.59 $26,567 - $30,171
168 Added 12.56%
1,506 $266,000
Q4 2020

Jan 13, 2021

SELL
$137.11 - $157.38 $17,550 - $20,144
-128 Reduced 8.73%
1,338 $214,000
Q3 2020

Nov 04, 2020

BUY
$140.38 - $153.83 $205,797 - $225,514
1,466 New
1,466 $218,000
Q3 2020

Oct 16, 2020

SELL
$140.38 - $153.83 $205,797 - $225,514
-1,466 Closed
0 $0
Q2 2020

Jul 07, 2020

SELL
$128.81 - $155.51 $9,145 - $11,041
-71 Reduced 4.62%
1,466 $206,000
Q1 2020

Apr 27, 2020

BUY
$111.14 - $153.99 $170,822 - $236,682
1,537 New
1,537 $201,000
Q3 2019

Oct 15, 2019

SELL
$126.95 - $142.14 $205,024 - $229,556
-1,615 Closed
0 $0
Q1 2019

Apr 30, 2019

BUY
$125.72 - $139.79 $4,525 - $5,032
36 Added 2.28%
1,615 $225,000
Q3 2018

Oct 10, 2018

BUY
$121.58 - $142.88 $191,974 - $225,607
1,579 New
1,579 $218,000
Q1 2018

Apr 16, 2018

SELL
$125.1 - $148.14 $167,383 - $198,211
-1,338 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $175,572 - $192,163
1,338
1,338 $173,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Santori & Peters, Inc. Portfolio

Follow Santori & Peters, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Santori & Peters, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Santori & Peters, Inc. with notifications on news.